Investing.com - Bioceres Crop (NASDAQ: BIOX) reported third quarter EPS of $0.14, $0.03 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $84M versus the consensus estimate of $103.84M.
Bioceres Crop's stock price closed at $12.35. It is down -7.21% in the last 3 months and up 4.13% in the last 12 months.
Bioceres Crop saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Bioceres Crop's stock price’s past reactions to earnings here.
According to InvestingPro, Bioceres Crop's Financial Health score is "good performance".
Check out Bioceres Crop's recent earnings performance, and Bioceres Crop's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar